Stay updated with breaking news from Research Collaborative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- A new study found that changes in specific genes may contribute each year to the roughly 400 sudden unexplained deaths in children (SUDC) aged...
/PRNewswire/ -- A new study found that changes in specific genes may contribute each year to the roughly 400 sudden unexplained deaths in children (SUDC) aged...
Patients with acute leukemia or myelodysplastic syndrome in an active state experienced significantly greater COVID-19 severity but not higher mortality due to the virus, according to research presented at ASH Annual Meeting and Exposition.The findings from the ASH Research Collaborative COVID-19 Registry for Hematology also showed patients with acute myeloid leukemia, acute lymphocytic leukemia
New findings provide preliminary evidence to use aggressive supportive treatment of COVID-19 in patients with acute leukemias and myelodysplastic syndromes.
The rate of death from COVID-19 is higher in patients with hematologic malignancies than in the general population, registry data suggest.